Literature DB >> 12445521

The significance of ammonia/gamma-aminobutyric acid (GABA) ratio for normality and liver disorders.

Brett I Cohen1.   

Abstract

Cohen has illustrated that extremely high Gamma-aminobutyric acid (GABA) levels in the urine and blood and high plasma ammonia were observed for an autistic male child diagnosed with infantile autism. GABA is a major inhibitory neurotransmitter of the mammalian brain and the enzyme responsible for catabolism is GABA-Transaminase (GABA-T). Elevated levels of ammonia in the plasma results in a decrease in the efficiency for the GABA-T enzyme and this results in higher GABA concentrations after regulation in the liver. It is postulated that a link between plasma ammonia and plasma GABA exists where the concentration of GABA in the plasma is directly related to the ammonia plasma concentration. A ratio of approximately 0.30 (plasma ammonia/GABA) is a consistent finding for normal subjects and for subjects with infantile autism and liver diseases such as hepatic encephalopathy. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445521     DOI: 10.1016/s0306-9877(02)00325-0

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Enhanced sedative efficacy and delayed recovery in propofol anesthesia in a rat model of hepatic cirrhosis.

Authors:  Xuexin Chen; Rui Yan; Zhixia Bai; Hanxiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Altered Urinary Amino Acids in Children With Autism Spectrum Disorders.

Authors:  Aiping Liu; Wei Zhou; Liuhong Qu; Fusheng He; Hui Wang; Yan Wang; Chunquan Cai; Xiaoge Li; Wenhao Zhou; Mingbang Wang
Journal:  Front Cell Neurosci       Date:  2019-01-25       Impact factor: 5.505

3.  An Effective Optical Dual Gas Sensor for Simultaneous Detection of Oxygen and Ammonia.

Authors:  Sajal Biring; Annada Sankar Sadhu; Moumita Deb
Journal:  Sensors (Basel)       Date:  2019-11-22       Impact factor: 3.576

4.  Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.

Authors:  Sergio Modafferi; Xiali Zhong; Andre Kleensang; Yohei Murata; Francesca Fagiani; David Pamies; Helena T Hogberg; Vittorio Calabrese; Herbert Lachman; Thomas Hartung; Lena Smirnova
Journal:  Environ Health Perspect       Date:  2021-07-14       Impact factor: 9.031

Review 5.  Profiles of urine and blood metabolomics in autism spectrum disorders.

Authors:  Narueporn Likhitweerawong; Chanisa Thonusin; Nonglak Boonchooduang; Orawan Louthrenoo; Intawat Nookaew; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.655

Review 6.  Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.

Authors:  Hui-Fei Zheng; Wen-Qiang Wang; Xin-Min Li; Gail Rauw; Glen B Baker
Journal:  Amino Acids       Date:  2016-09-29       Impact factor: 3.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.